Percogesic Tablet, Coated
NDC 63029-051
Product Information
Percogesic (magnesium salicylate) is a OTC MONOGRAPH DRUG-approved product labeled by Medtech Products Inc.. This product is primarily utilized in pharmaceutical processing or compounding. It is supplied as a white tablet, coated for oral administration. This product entry covers the primary NDC 63029-051 and its associated package configuration. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Clinical Specifications
Labeler & Regulatory Data
Marketing Timeline
Product Characteristics
BR
Code Structure Chart
Product Details
What is NDC 63029-051?
What are the uses of this product?
What are Active Ingredients of this product?
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- MAGNESIUM SALICYLATE (UNII: 41728CY7UX)
- SALICYLIC ACID (UNII: O414PZ4LPZ) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)
- HYPROMELLOSE, UNSPECIFIED (UNII: 3NXW29V3WO)
- MAGNESIUM STEARATE (UNII: 70097M6I30)
- MICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U)
- SILICON DIOXIDE (UNII: ETJ7Z6XBU4)
- STEARIC ACID (UNII: 4ELV7Z65AP)
- TALC (UNII: 7SEV7J4R1U)
- TITANIUM DIOXIDE (UNII: 15FIX9V2JP)
What is the NDC to RxNorm Crosswalk for this product?
- RxCUI: 1233718 - Percogesic Backache Relief Maximum Strength 580 MG Oral Tablet
- RxCUI: 1233718 - magnesium salicylate 580 MG Oral Tablet [Percogesic Backache]
- RxCUI: 1233718 - Percogesic Backache 580 MG Oral Tablet
- RxCUI: 198742 - magnesium salicylate 580 MG Oral Tablet
- RxCUI: 198742 - magnesium salicylate 580 MG (as magnesium salicylate anhydrous 467 MG) Oral Tablet
* Please review the full disclaimer at the bottom of this page.